Used primarily as an intermediate in the synthesis of carbonic anhydrase inhibitors, this compound plays a key role in developing pharmaceuticals for treating glaucoma, epilepsy, and certain types of edema. Its structure allows for strong binding to carbonic anhydrase enzymes, enhancing the efficacy of drugs targeting these conditions. Additionally, it serves in research settings for designing new sulfonamide-based bioactive molecules with potential antimicrobial or anticancer properties.